MRNA LIGHTNING

Serial Number 79347337
Registration 7403950
700

Registration Progress

Application Filed
May 25, 2022
Under Examination
Approved for Publication
Feb 28, 2024
Published for Opposition
Mar 19, 2024
Registered
Jun 4, 2024

Trademark Image

MRNA LIGHTNING

Basic Information

Serial Number
79347337
Registration Number
7403950
Filing Date
May 25, 2022
Registration Date
June 4, 2024
Published for Opposition
March 19, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Jun 4, 2024
Registration
Registered
Classes
005 042

Rights Holder

Anima Biotech Inc.

03
Address
75 Claremont Rd, Ste 102
Bernardsville NJ 07924
US

Ownership History

Anima Biotech Inc.

Original Applicant
03
US

Anima Biotech Inc.

Owner at Publication
03
US

Anima Biotech Inc.

Original Registrant
03
US

Legal Representation

Attorney
Jonathan D. Reichman, Esq.

USPTO Deadlines

Next Deadline
1667 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-06-04)
Due Date
June 04, 2030
Grace Period Ends
December 04, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

35 events
Date Code Type Description Documents
Nov 30, 2024 FINV P FINAL DECISION TRANSACTION PROCESSED BY IB Loading...
Nov 14, 2024 FIMP P FINAL DISPOSITION PROCESSED Loading...
Nov 14, 2024 FICS P FINAL DISPOSITION NOTICE SENT TO IB Loading...
Sep 4, 2024 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Loading...
Jun 4, 2024 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Jun 4, 2024 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Mar 19, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Mar 19, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Feb 28, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Feb 28, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Feb 10, 2024 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Feb 5, 2024 OPNX P NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB Loading...
Jan 24, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jan 24, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jan 23, 2024 ALIE A ASSIGNED TO LIE Loading...
Jan 17, 2024 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Loading...
Jan 17, 2024 OPNR P NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB Loading...
Oct 4, 2023 RFNT P REFUSAL PROCESSED BY IB Loading...
Sep 5, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Aug 30, 2023 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Aug 30, 2023 GNRT O NON-FINAL ACTION E-MAILED Loading...
Aug 30, 2023 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jun 27, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jun 26, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jun 26, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
May 24, 2023 RFNT P REFUSAL PROCESSED BY IB Loading...
May 4, 2023 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Loading...
May 4, 2023 RFRR P REFUSAL PROCESSED BY MPU Loading...
Mar 16, 2023 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Loading...
Mar 15, 2023 CNRT R NON-FINAL ACTION WRITTEN Loading...
Mar 14, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Mar 4, 2023 NREP P NEW REPRESENTATIVE AT IB RECEIVED Loading...
Aug 16, 2022 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Aug 12, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Aug 11, 2022 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB Loading...

Detailed Classifications

Class 005
Pharmaceuticals, namely, small molecule therapeutic preparations for the regulation of mRNA translation and mRNA biology, used in the treatment of fibrosis, cancers, neurological diseases, infectious diseases, genetic diseases, and other diseases
Class 042
Research, analysis, and development of pharmaceuticals, namely, small molecule therapeutic preparations for the regulation of mRNA translation and mRNA biology, used in the treatment of fibrosis, cancers, neurological diseases, infectious diseases, genetic diseases, and other diseases

Classification

International Classes
005 042

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"MRNA"